AlwaysraiseVC

AlwaysraiseVC is a California-based venture capital firm that invests in early-stage startups focused on medical devices, biopharma, digital health, and clinical-stage biotechnology. Operating with fewer than 10 employees, the firm provides capital and strategic guidance to companies developing digital therapeutics and software as a medical device. The firm's portfolio includes investments in healthcare technology developers such as Zap Surgical, Oncodisc Inc., which was later acquired by PAVmed as Veris Health, and Savage Medical Inc., now known as Averto Medical. In late 2023, AlwaysraiseVC participated in an oversubscribed financing round exceeding $3 million for Savage Medical, a company established by executives who previously raised $76 million before an acquisition by 3M. The venture capital firm was founded by Gabriel Morris, who leads the organization alongside Joseph DeCorte and Ken Wang, though its exact founding year remains undisclosed.

High-Level Overview

AlwaysraiseVC, also known as AlwaysraiseVentures, is a venture capital firm specializing in investments within the medical device and biotechnology sectors. Their mission centers on infusing capital into innovative healthcare startups, particularly those developing cutting-edge medical devices and biopharmaceuticals. By focusing on clinical-stage companies, AlwaysraiseVC aims to accelerate the development and commercialization of breakthrough medical technologies that address critical health challenges. Their investment philosophy emphasizes supporting companies with strong scientific foundations and promising clinical pipelines, contributing significantly to the advancement of the healthcare startup ecosystem.

Origin Story

AlwaysraiseVC was founded with a focus on the healthcare and life sciences sectors, though specific founding year and key partners are not publicly detailed. The firm has evolved to concentrate on clinical-stage biotechnology and medical device companies, as evidenced by their portfolio including firms that have completed NASDAQ IPOs and those developing novel therapies and medical technologies. Their involvement in oversubscribed financings alongside other specialized investors like Synergy Ventures and Life Science Angels highlights their active role in supporting promising medical innovations.

Core Differentiators

• Specialized Focus: Concentrates exclusively on medical devices and clinical-stage biotechnology, allowing deep sector expertise.
• Strategic Capital Infusion: Provides critical funding at pivotal stages of clinical development, enabling companies to advance toward commercialization.
• Strong Network: Collaborates with other life science-focused investors, enhancing deal flow and co-investment opportunities.
• Track Record: Participation in oversubscribed financings and backing companies that have reached public markets demonstrates investment success.
• Operating Support: Likely offers sector-specific guidance given their niche focus, though explicit operating support details are not publicly available.

Role in the Broader Tech Landscape

AlwaysraiseVC operates at the intersection of healthcare innovation and venture capital, riding the trend of increasing demand for advanced medical technologies and biopharmaceutical solutions. The timing is favorable due to growing global healthcare needs, advances in medical science, and a robust regulatory environment supporting clinical-stage development. By funding companies that develop novel therapies and devices, AlwaysraiseVC influences the broader ecosystem by accelerating the translation of scientific breakthroughs into market-ready products, ultimately impacting patient care and health outcomes.

Quick Take & Future Outlook

Looking ahead, AlwaysraiseVC is positioned to continue capitalizing on the expanding biotech and med-tech sectors, especially as precision medicine, cell therapies, and innovative medical devices gain traction. Trends such as personalized medicine, digital health integration, and regenerative therapies will likely shape their investment focus. Their influence may grow as they back more companies through critical clinical milestones and public offerings, reinforcing their role as a key enabler of healthcare innovation.

In summary, AlwaysraiseVC stands out as a specialized venture capital firm dedicated to advancing medical technology and biotechnology startups, leveraging sector expertise and strategic capital to foster impactful healthcare solutions.